Vivid E9 Aims for Endocardial Definition
October 31, 2008
GE Healthcare’s recently released Vivid E9 ultrasound features Accelerated Volume Architecture (AVA), which not only makes single beat acquisition possible but, working alongside Extended Signal transducer technology in each probe, it reportedly delivers a leap in 2D, 4D and shared service image quality across the entire patient population.
The new M5S transducer takes the matrix array technology and marries this with single crystal technology to reportedly provide better endocardial definition, texture and crisper valves across a wider range of frequencies than traditional transducers.
More like this
- GE Healthcare Launches Vivid E9, Vivid q, Intracardiac Echo at AHA
- GE Healthcare Launches Vivid E9, Vivid q, Intracardiac Echo at AHA
- Vivid E9 4D Cardiovascular Ultrasound Helps Assess Heart Failure
- New Cardiovascular US Provides Mobility, Full Size LCD Monitor
- Hybrid System Adds New Features for 2008




